MiniMed Group, Inc. (NASDAQ:MMED)
| Market Cap | 5.49B+2.5% |
| Revenue (ttm) | 3.22B |
| Net Income | -329.00M |
| EPS | -1.10 |
| Shares Out | 280.84M |
| PE Ratio | n/a |
| Forward PE | 28.78 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | 25.50(+30.37%) |
| Earnings Date | n/a |
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About MMED
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
$MMED stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MMED holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MMED's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MMED Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MMED Revenue by Segment or Geography
As of: Q3 2026 (Jul 31, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New MMED patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MMED from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MMED
| ETF | Est. Holding Size |
|---|---|
| FPXFirst Trust US Equity Opportunities ETF | $15.87M |
| IWMiShares Russell 2000 ETF | $14.84M |
| VXFVanguard Extended Market ETF | $6.64M |
| IWNiShares Russell 2000 Value ETF | $5.13M |
| VTWOVanguard Russell 2000 ETF | $3.35M |
| MGMTBallast Small/Mid Cap ETF | $3.13M |
Estimated from each fund’s disclosed top holdings × AUM
MMED Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MMED’s recent data — informational, not investment advice